VANCOUVER, BC–(Marketwired – May 19, 2016) – LED Medical Diagnostics Inc. (“LED” or the “Company”) (TSX VENTURE: LMD)
(OTCQX: LEDIF) (FRANKFURT: LME) is pleased to announce that it has retained Bristol Capital Ltd. as its investor relations advisor. Bristol has been retained to assist LED Medical in achieving greater visibility amongst current and prospective investors through the dissemination and communication of corporate materials, conference calls and road show activity.
Bristol is headquartered in Vaughan, Ontario and does not presently own any securities of LED. Under the terms of the agreement, Bristol will receive $7,000 per month and 300,000 stock options exercisable at CDN$0.18 per share with an option term of 3 years. Vesting provisions provide that 25% of the options will vest quarterly over the first year of the agreement. The agreement is for an initial 12-month term with a provision for automatic 12-month renewals. The agreement to retain Bristol Capital Ltd. is subject to TSX Venture Exchange approval.
Bristol has an outstanding reputation of helping small emerging companies better communicate and build awareness with the professional investor community and we look forward to working with them in that regard,” stated David Gane, Company CEO.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the TSX-V under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information, call 884.952.7327 or visit www.leddental.com/investor-relations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Investor Relations Contact:
Bristol Capital
Glen Akselrod
Phone: 905.326.1888 ext 10
Email: [email protected]
Media Contact:
LED Dental
Chris Koch
Phone: 678.293.9413
Email: [email protected]
Corporate Contact:
LED Medical
David Gane
CEO
Phone: 604.434.4614 ext 227
Email: [email protected]
